Der Wind bleibt rau an den Aktienmärkten. Nur wenige Scale-Titel können sich halten, das Thema der Stunde sind die Lieferengpässe. Ein aufgehender Stern ist das Biotech-Unternehmen Formycon – mit einem Kursplus von 26 Prozent seit Jahresanfang. Drei...

The wind remains rough on the stock markets. Only a few scale stocks can hold their ground; the topic of the hour is supply bottlenecks. One rising star is the biotech company Formycon - with a price increase of 26 percent since the beginning of the...

The wind remains rough on the stock markets. Only a few scale stocks can hold their ground; the topic of the hour is supply bottlenecks. One rising star is the biotech company Formycon - with a price increase of 26 percent since the beginning of the...

The wind remains rough on the stock markets. Only a few scale stocks can hold their ground; the topic of the hour is supply bottlenecks. One rising star is the biotech company Formycon - with a price increase of 26 percent since the beginning of the...